Shimousa Hematology Study Group
1 clinical trials · Sponsor
◉ Watch Shimousa Hematology Study Group
| Record | Firm | Date |
|---|---|---|
| Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial (NCT01627132) | Shimousa Hematology Study Group | 2012-02-01 |
Track Shimousa Hematology Study Group automatically
Every clearance here is in the API, with alerts when new ones post.